Akorn Pharmaceuticals

Akorn Investor Relations

Press Releases

Date Title  
03/01/19 Akorn Comments on Favorable Court Order Printer Friendly Version
02/28/19 Akorn Provides Fourth Quarter and Full Year 2018 Results Printer Friendly Version
02/20/19 Akorn Comments on Fresenius’ Proposed Amended Claims Printer Friendly Version
02/11/19 Akorn to Report Fourth Quarter and Full Year 2018 Results Printer Friendly Version
01/28/19 Akorn Announces New Executive and Board Appointments Printer Friendly Version
01/09/19 Akorn Receives FDA Warning Letter Printer Friendly Version
01/08/19 Akorn Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Printer Friendly Version